February 2, 2015 / 4:18 PM / 2 years ago

BUZZ-Intellipharmaceutics International Inc: Teva to market drug in US

1 Min Read

** Canadian drugmaker's U.S.-listed shares up 7.8 pct at $2.20

** Toronto-listed shares up 8.5 percent at C$2.80

** Israel-based Teva Pharmaceutical will exclusively market Intellipharmaceutics' generic oral drugs in the United States

** Intellipharmaceutics' Toronto-listed stock declined about 33 pct over last 12 months

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below